New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
17:16 EDTAGN, VOD, FCX, CNO, CBS, AAL, PXD, HES, GM, TMO, DG, DTV, COV, HSH, QCOR, SHPG, CIE, MNK, FDO, DLRPaulson & Co gives quarterly update on stakes
NEW STAKES: Allergan (AGN), DIRECTV (DTV), Covidien (COV), Hillshire Brands (HSH), and Questcor (QCOR). INCREASED STAKES: Shire (SHPG), Cobalt (CIE), Mallinckrodt (MNK), Family Dollar (FDO), and Dollar General (DG). DECREASED STAKES: Thermo Fisher (TMO), Vodafone (VOD), Freeport-McMoRan (FCX), CNO Financial (CNO), and CBS (CBS). LIQUIDATED STAKES: American Airlines (AAL), Pioneer Natural Resources (PXD), Hess (HES), General Motors (GM), and Digital Realty Trust (DLR).
News For AGN;DTV;COV;HSH;QCOR;SHPG;CIE;MNK;FDO;DG;TMO;VOD;FCX;CNO;CBS;AAL;PXD;HES;GM;DLR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
October 9, 2014
08:27 EDTVODVodafone downgraded to Reduce from Neutral at Nomura
Subscribe for More Information
07:31 EDTDLRUBS to hold a tour
Subscribe for More Information
06:49 EDTAGNAllergan cites momentum from robust growth of worldwide markets
The company also cites increases in market share in most categories, many regulatory approvals for new products in the U.S. and internationally, and targeted investments to create and grow new products and new categories. Exceptional growth in EPS from the acceleration in sales but also in leveraging of sales and marketing expenditures. The benefits from Allergan’s previously announced restructuring program will be reflected in the Company’s actual results beginning in the fourth quarter of 2014 and continuing through 2015.
06:47 EDTAGNAllergan sees FY16 non-GAAP EPS $10.25
06:47 EDTAGNAllergan sees FY15 non-GAAP EPS $8.60, consensus $8.25
Subscribe for More Information
06:47 EDTAGNAllergan sees FY14 non-GAAP EPS $6.20-$6.25, consensus $5.81
Subscribe for More Information
06:46 EDTAGNAllergan raises Q3 EPS to $1.76-$1.78 from $1.44-$1.47, consensus $1.48
Expects Q3 product net sales to increase in excess of 17% in dollars compared to product net sales from 3Q13.
06:39 EDTMNKMallinckrodt price target raised to $110 from $95 at Jefferies
Jefferies raised its price target for Mallinckrodt shares to $110 ahead of the company's October 14 analyst day and keeps a Buy rating on the name. The firm says recent trends show continued strength for Ofirmev.
05:22 EDTSHPGShire provides regulatory update on SHP 465
Subscribe for More Information
October 8, 2014
18:20 EDTFCXFreeport California assets may receive bid from McClendon, Bloomberg reports
Aubrey McClendon is mulling a purchase of Freeport McMoRan's assets in California for up to $5B, Bloomberg reports, citing people with knowledge of the matter. McClendon's American Energy Partners has been looking to raise capital to fund the potential deal, and the company would turn Freeport's assets into a newly created operating unit, the people added. Freeport McMoRan is speaking with other potential suitors, and the dead is not finalized, according to the people. Reference Link
16:10 EDTAGNAllergan initiated with a Buy at Deutsche Bank
Subscribe for More Information
15:25 EDTFDONotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include PepsiCo (PEP), consensus $1.29; Family Dollar (FDO), consensus 77c; Lindsay (LNN), consensus 57c.
12:52 EDTFCXFreeport faces mounting pressure to improve safety at copper mine, Reuters says
Workers at Freeport McMoRan's Indonesia copper mine are looking for face-to-face talks with local management and may commence a mine blockade or strike action following a fatal accident at the mine, Reuters reports, citing union official Albar Sabang. If workers safety concerns and other demands are ignored by management, fresh protests and strikes may occur which can hinder copper exports for Freeport, Sabang added. Reference Link
10:46 EDTDTV, COVOptions with decreasing implied volatility
Subscribe for More Information
08:42 EDTAGNSalix shares should be bought on weakness, says Sterne Agee
After Reuters yesterday afternoon reported that Actavis (ACT) plans to make a new merger approach to Allergan (AGN), Sterne Agee believes that Salix's standalone value is $162. The firm expects the shares to reach that level following approval of its Xifaxan IBS-D drug after the February 2015 PDUFA date.
08:13 EDTAALAmerican Airlines sees 2014 total system capacity up 2.2% vs. 2013
Sees Q3 pre-tax margin 10%-12%. Sees Q3 CASM flat to up 2% ex-fuel, sees Q4 CASM up 2%-4% ex-fuel, sees FY14 CASM up 2%-4% ex-fuel. 2014 total system capacity is expected to be up approximately 2.2 percent vs. 2013 primarily due to more active aircraft and larger gauge aircraft replacing smaller gauge legacy aircraft. Full year mainline capacity is also expected to be up approximately 2.4 percent year-over-year, of which international capacity is expected to be up approximately 5 percent and domestic capacity is expected to be up approximately 1 percent vs. 2013. For the third quarter 2014, AAG expects to pay an average of between $2.95 and $3.00 per gallon of mainline jet fuel. The Company expects to take delivery of 84 mainline aircraft during 2014, consisting of 10 A319s, 43 A321s, 3 A332s, 20 B738s, 2 B788s and 6 B773s. In addition, the company expects to retire 6 A320s, 14 B734s, 19 B757s, 14 B762s and 26 MD80s by the end of 2014. In 2014, the Company expects to take delivery of 15 CRJ900 aircraft at its wholly owned subsidiary PSA Airlines. In addition, the Company’s partner airlines are expected to take delivery of 10 CRJ900 aircraft and 24 E175 aircraft. The Company expects to retire 40 ERJ140 aircraft and 2 Dash 8-100 aircraft.
08:02 EDTAALAmerican Airlines reports September total RPMs down 0.2% to 16.9B
Subscribe for More Information
07:19 EDTAGN, MNKCBI to hold a conference
Subscribe for More Information
06:48 EDTVODSwisscom mulls $6.3B Fastweb deal as Vodafone waits, Reuters says
Subscribe for More Information
06:23 EDTAGNActavis more inclined to pursue Allergan over Salix, says Citigroup
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use